Brachytherapy
Volume 6, Issue 1 , Pages 9-15 , January 2007

Initial analysis of Pro-Qura: A multi-institutional database of prostate brachytherapy dosimetry

  • Gregory S. Merrick

      Affiliations

    • Schiffler Cancer Center, Wheeling Hospital, Wheeling, WV
    • Wheeling Jesuit University, Wheeling, WV
    • Corresponding Author InformationCorresponding author. Schiffler Cancer Center, Wheeling Hospital, 1 Medical Park, Wheeling, WV 26003-6300, USA. Tel.: +1-304-243-3490; fax: +1-304-243-5047.
    • ,
  • Peter D. Grimm

      Affiliations

    • Seattle Prostate Institute, Seattle, WA
    • ProQura, Seattle, WA
    • ,
  • John Sylvester

      Affiliations

    • Seattle Prostate Institute, Seattle, WA
    • ProQura, Seattle, WA
    • ,
  • John C. Blasko

      Affiliations

    • Seattle Prostate Institute, Seattle, WA
    • ProQura, Seattle, WA
    • ,
  • Wayne M. Butler

      Affiliations

    • Schiffler Cancer Center, Wheeling Hospital, Wheeling, WV
    • Wheeling Jesuit University, Wheeling, WV
    • ,
  • Zachariah A. Allen

      Affiliations

    • Schiffler Cancer Center, Wheeling Hospital, Wheeling, WV
    • Wheeling Jesuit University, Wheeling, WV
    • ,
  • Usman-Ul-Haq Chaudhry

      Affiliations

    • Schiffler Cancer Center, Wheeling Hospital, Wheeling, WV
    • ,
  • Anthony Mazza

      Affiliations

    • Schiffler Cancer Center, Wheeling Hospital, Wheeling, WV
    • Wheeling Jesuit University, Wheeling, WV
    • ,
  • Mike Sitter

      Affiliations

    • Seattle Prostate Institute, Seattle, WA
    • ProQura, Seattle, WA

Received 21 July 2006 ,Revised 24 October 2006 ,Accepted 29 October 2006.

References 

  1. Merrick GS, Wallner KE, Butler WM. Permanent interstitial brachytherapy for the management of carcinoma of the prostate gland. J Urol. 2003;169:1643–1652
  2. Stock RG, Stone RN, Tabert A, et al. A dose-response study for I-125 prostate implants. Int J Radiat Oncol Biol Phys. 1998;41:101–108
  3. Kollmeier MA, Stock RG, Stone N. Biochemical outcomes after prostate brachytherapy with 5-year minimal follow-up: Importance of patient selection and implant quality. Int J Radiat Oncol Biol Phys. 2003;57:645–653
  4. Potters L, Huang D, Calugaru E, et al. Importance of implant dosimetry for patients undergoing prostate brachytherapy. Urol. 2003;62:1073–1077
  5. Merrick GS, Wallner KE, Butler WM. Minimizing prostate brachytherapy-related morbidity. Urology (Review). 2003;62:786–792
  6. Lee WR, DeGuzman AF, Bare RL, et al. Postimplant analysis of transperineal interstitial permanent prostate brachytherapy: Evidence for a learning curve in the first year at a single institution. Int J Radiat Oncol Biol Phys. 2000;46:83–88
  7. Merrick GS, Butler WM, Wallner KE, et al. Variability of prostate brachytherapy preimplant dosimetry: A multi-institutional analysis. Brachytherapy. 2005;4:241–251
  8. Nag S, Bice W, DeWyngaert K, et al. The American Brachytherapy Society recommendations for permanent prostate brachytherapy postimplant dosimetric analysis. Int J Radiat Oncol Biol Phys. 2000;46:221–230
  9. Mettlin C. Changes in patterns of prostate cancer care in the United States: Results of an American College of Surgeons Commission on Cancer Studies, 1974-1993. Prostate. 1997;32:221–226
  10. Hanks GE, Krall JM, Hanlon EL, et al. Patterns of care and RTOG studies in prostate cancer: Long-term survival, hazard rate observations, and possibilities of cure. Int J Radiat Oncol Biol Phys. 1993;28:39–45
  11. McNeely LK, Stone NN, Presser J, et al. Influence of prostate volume on dosimetry results in real-time 125I seed implantation. Int J Radiat Oncol Biol Phys. 2004;58:292–299
  12. Bice WS, Prestidge BR, Grimm PD, et al. Centralized multi-institutional postimplant analysis for interstitial prostate brachytherapy. Int J Radiat Oncol Biol Phys. 1998;41:921–927
  13. Lee WR, Roach M, Michalski J, et al. Interobserver variability leads to significant differences in quantifiers of prostate implant adequacy. Int J Radiat Oncol Biol Phys. 2002;45:457–461
  14. Han BH, Wallner KE, Merrick GS, et al. The effect of interobserver differences in post-implant prostate CT image interpretation on dosimetric parameters. Med Phys. 2003;30:1096–1102
  15. Merrick GS, Butler WM, Dorsey AT, Lief JH. The dependence of prostate postimplant dosimetric quality on CT volume determination. Int J Radiat Oncol Biol Phys. 1999;44:1111–1117

PII: S1538-4721(06)00275-3

doi: 10.1016/j.brachy.2006.10.002

Brachytherapy
Volume 6, Issue 1 , Pages 9-15 , January 2007

Article Tools

* Image Usage & Resolution